SRXH stock (SRXH): notice to sell 37,007 common shares filed

Rhea-AI Filing Summary

A holder of SRXH common stock filed a notice of intent to sell 37,007 shares through Charles Schwab on the NYSE, with an aggregate market value of 14591.00 and an approximate sale date of 12/03/2025. The table reports 24,853,633 shares of this class outstanding. Most of the shares to be sold were originally acquired from the issuer as executive compensation between 2022 and 2024, with an additional 5,000 shares purchased in the open market on 11/20/2024 for cash.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab Corporation 3000 Schwab Way Westlake TX 76262	37007	14591.00	24853633	12/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/01/2022	Executive Compensation	Issuer			585	02/01/2022	Executive Compensation
Common	11/10/2022	Executive Compensation	Issuer			928	11/10/2022	Executive Compensation
Common	01/09/2023	Executive Compensation	Issuer			562	01/09/2023	Executive Compensation
Common	01/10/2023	Executive Compensation	Issuer			4059	01/10/2023	Executive Compensation
Common	02/02/2023	Executive Compensation	Issuer			409	02/02/2023	Executive Compensation
Common	09/05/2023	Executive Compensation	Issuer			17046	09/05/2023	Executive Compensation
Common	02/01/2024	Executive Compensation	Issuer			8418	02/01/2024	Executive Compensation
Common	11/20/2024	Open Market	Open Market			5000	11/20/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many SRXH shares are planned to be sold under this Form 144 notice?

The notice covers the proposed sale of 37,007 shares of SRXH common stock, to be sold through Charles Schwab on the NYSE.

What is the aggregate market value of the SRXH shares to be sold?

The planned sale of 37,007 SRXH common shares has an aggregate market value of 14591.00 as reported in the notice.

How many SRXH common shares are reported as outstanding in this filing?

The table lists 24,853,633 SRXH common shares as outstanding for the class of securities referenced in the planned sale.

When is the approximate sale date for the SRXH shares in this Form 144?

The approximate date of sale for the 37,007 SRXH common shares is reported as 12/03/2025.

How were the SRXH shares being sold originally acquired?

According to the notice, most of the SRXH common shares were acquired from the issuer as executive compensation on several dates between 02/01/2022 and 02/01/2024, and 5,000 shares were acquired in an open market transaction on 11/20/2024 for cash.

Which broker is handling the planned SRXH share sale?

The planned sale of 37,007 SRXH common shares will be executed through Charles Schwab Corporation, located at 3000 Schwab Way, Westlake, TX 76262.